Icentia Receives U.S. Food and Drug Administration (FDA) Clearance for CardioSTAT®
Legacy MEDSearch
APRIL 6, 2023
announced that it has received FDA 510(k) clearance for CardioSTAT, an ambulatory, continuous ECG monitoring solution that relies on a wire free, single-use recorder. The FDA clearance opens the door to the world’s largest medical device market. Icentia Inc., “This approval marks a key milestone for our company.
Let's personalize your content